Description
BioSpectra is a leading manufacturer of premium pharmaceutical ingredients and bulk cGMP fine chemicals, primarily serving the global BioPharma sector. Established in 1994, BioSpectra operates the only truly dedicated, USFDA registered and inspected GMP facility, which spans 175,000 square feet of privately owned manufacturing and storage space. The company is renowned for producing the highest quality, highest compliance bulk GMP biological buffers and denaturants. Additionally, BioSpectra offers contract GMP small molecule synthesis for active pharmaceutical ingredients (APIs), excipients, and key intermediates, alongside solvent and solution compounding and purification of critical GMP process fine chemicals in both small and large-scale quantities.
Services include:
– Regulatory Services
– Active Pharmaceutical Ingredients (APIs)
– Analytical Services
– Intermediates
– Fine Chemicals
– GMP Biological Buffers
– GMP Buffer Solutions
– Solvent and Solution Compounding
– Contract Manufacturing for Small Molecule Synthesis
– Purification of Process Fine Chemicals
– New Chemical Entities (NCEs)
BioSpectra is committed to enhancing every stage of the drug manufacturing process with its innovative purification and synthetic capabilities. To learn more about BioSpectra, please visit biospectra.us.
Contact Information
Related Listings

CDMO Live Europe 2026
Experience the future of external manufacturing at CDMO Live, Rotterdam.
19-21st May 2026

External Manufacturing Leaders Rotterdam 2026
Exclusive event for senior external manufacturing leaders. 26th May 2026 at CDMO Live











